Last updated: October 04, 2026

Application No. 17/049,006

DHA ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS

Final Rejection

Filed

Oct 19, 2020

Priority

Apr 25, 2018 — EU 18169368.0 +2 more

Examiner

ABDALHAMEED, MANAHIL MIRGHANI ALI

Art Unit

1622

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Nuseed Nutritional US Inc.

OA Round

6 (Final)

This examiner grants 50% of cases after interview

— +38.2% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 151 resolved cases, 2023–2026

Examiner Intelligence

ABDALHAMEED, MANAHIL MIRGHANI ALI View full profile →

Grants 50% of resolved cases

Career Allowance Rate

76 granted / 151 resolved

-9.7% vs TC avg

Strong +38% interview lift

Without

With

+38.2%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

35 currently pending

Career history

189

Total Applications

across all art units

Statute-Specific Performance

§101

2.8%

-37.2% vs TC avg

§103

40.0%

+0.0% vs TC avg

§102

16.7%

-23.3% vs TC avg

§112

19.7%

-20.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 151 resolved cases

Prosecution Timeline

Show 9 earlier events

Dec 19, 2024

Non-Final Rejection mailed

Jun 16, 2025

Response Filed

Jul 29, 2025

Final Rejection mailed

Dec 01, 2025

Request for Continued Examination

Dec 04, 2025

Response after Non-Final Action

Dec 22, 2025

Non-Final Rejection mailed

Jun 22, 2026

Response Filed

Aug 20, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/032,963

Patent 12715867

Agonists Of Free Fatty Acid Receptor 1 And Their Use In Diseases Associated With Said Receptor

3y 4m to grant Granted Aug 25, 2026

16/974,157

Patent 12702653

EYE DROPS WITH CITRIC ACID AS THE SOLE ACTIVE INGREDIENT

5y 9m to grant Granted Aug 11, 2026

17/269,244

Patent 12668568

ADAMANTANYL-SUBSTITUTED BENZAMIDE COMPOUNDS AND THEIR USE AS P2X7 RECEPTOR ANTAGONISTS

5y 4m to grant Granted Jun 30, 2026

19/225,092

Patent 12667567

Method of Preventing Blast-Induced Loss of Cochlear and Vestibular Hair Cells and Auditory Spiral Ganglion Neurons

1y 0m to grant Granted Jun 30, 2026

18/767,610

Patent 12661360

READY TO USE NON-AQUEOUS SOLUTIONS OF LAMOTRIGINE

1y 11m to grant Granted Jun 23, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8

Expected OA Rounds

50%

Grant Probability

88%

With Interview (+38.2%)

2y 10m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 151 resolved cases by this examiner. Grant probability derived from career allowance rate.